| Dr Camille Anne Dumas, DO | |
|
47 New Scotland Avenue, Radiology Dept, Albany, NY 12208-3412 | |
| (518) 262-3277 | |
| Not Available |
| Full Name | Dr Camille Anne Dumas |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 10 Years |
| Location | 47 New Scotland Avenue, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851710859 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 299556 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Columbia Memorial Hospital | Hudson, NY | Hospital |
| Saratoga Hospital | Saratoga springs, NY | Hospital |
| Glens Falls Hospital | Glens falls, NY | Hospital |
| St Peter's Hospital | Albany, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia Memorial Hospital | 5092709410 | 174 |
| Ellis Hospital | 5890607410 | 222 |
| Community Care Physicians Pllc | 8022904473 | 363 |
| Albany Medical Center Hospital | 8224018999 | 50 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
| Entity Name | Ellis Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487644993 PECOS PAC ID: 5890607410 Enrollment ID: O20031103000406 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
| Entity Name | Columbia Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083639587 PECOS PAC ID: 5092709410 Enrollment ID: O20040409000109 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982634804 PECOS PAC ID: 1759293111 Enrollment ID: O20040722001091 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
| Entity Name | Albany Medical Center Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609806520 PECOS PAC ID: 8224018999 Enrollment ID: O20040722001140 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
| Entity Name | Community Care Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922048370 PECOS PAC ID: 8022904473 Enrollment ID: O20080130000272 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Camille Anne Dumas, DO 6 Wellness Way Ste 201, Latham, NY 12110-2156 Ph: (518) 782-3700 | Dr Camille Anne Dumas, DO 47 New Scotland Avenue, Radiology Dept, Albany, NY 12208-3412 Ph: (518) 262-3277 |
News Archive
Ampio Pharmaceuticals, Inc. today announced three peer-review publications that report the multifaceted and synergistic effects of Ampion in the treatment of osteoarthritis in the knee.
It's no secret that China is faced with some of the world's worst pollution. Until now, however, information on the magnitude, scope and impacts of a major contributor to that pollution - human-caused nitrogen emissions - was lacking.
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the new CARTO 3 MEM (Multi-Electrode Mapping) Version in the United States.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
› Verified 6 days ago
Robert A Belgam, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Stratton Va Medical Center, Albany, NY 12208 Phone: 518-626-6650 Fax: 518-626-6644 | |
Mr. Sreenivas Garla, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Radiology Dept, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
David Jahangir, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 | |
Dr. S Rao Aravapalli, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Dept. Of Radiology, Albany, NY 12208 Phone: 518-262-3277 Fax: 518-262-4210 | |
Dr. Heidi Dambach, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-3277 | |
Sean Peter Roddy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 391 Myrtle Ave., Suite 5, The Vascular Group, Pllc, Albany, NY 12208 Phone: 518-262-5640 Fax: 518-262-9413 | |
Dena Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1401 |